Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Copper (II) complexes involving quinazolinone Schiff base ligands: In vitro study of cytotoxic, genotoxic and DNA-protective potential in human hepatoma HepG2 cell line.

Created on 15 Nov 2026

Authors

Eva Horváthová, Peter Hergott, Terézia Zajičková, Jana Hricovíniová, Eliška Gálová, Michal Hricovíni, Andrea Ševčovičová, Zuzana Hricovíniová

Published in

Mutation research. Genetic toxicology and environmental mutagenesis. Volume 915. Pages 503964. Epub Oct 09, 2026.

Abstract

DNA oxidation damage contributes to carcinogenesis and limits the efficacy of many chemotherapeutics. Although platinum‑based drugs remain crucial in cancer therapy, their clinical use is restricted by toxicity and acquired resistance. However, quinazolinone derivatives have recently attracted attention as scaffolds with promising biological activities. Among these, Schiff bases are of particular interest because they can provide suitable ligands for the complexation with metals, making them a potential substitute for cisplatin. Therefore, in the search for new anticancer agents, Cu(II) complexes based on 2,3-substituted quinazolinones have been studied in detail. The radical scavenging/reducing efficiency and DNA-protective effects were monitored using DPPH, FRAP and DNA topology assays. Ligands and Cu(II) complexes, were screened for their in vitro cytotoxic, genotoxic, and protective activity in human hepatocarcinoma (HepG2) cells using the MTT and Comet assays. The results showed that compounds studied are redox-active agents. Cu(II) complexes exhibited higher DPPH radical-scavenging activity in comparison with their corresponding free ligands; they manifested comparable effects in ferric reducing power as well as in DNA topology assays. The cellular assays revealed markedly higher cytotoxicity of Cu(II) complexes compared with the corresponding free ligands. In the presence of H₂O₂, C1 significantly enhanced DNA damage, whereas C2 did not alter the level of DNA damage induced by H₂O₂ alone. On the contrary, ligands exhibited much lower toxicity and significant protection of HepG2 cells against H2O2. The incorporation of Cu(II) ions into quinazolinone Schiff base ligands substantially alters their biological activity, shifting their profile from DNA‑protective to cytotoxic/pro‑oxidant. DFT calculations were performed for both Cu(II) complexes to investigate molecular features that may contribute to their different biological activity. These results highlight the potential of quinazolinone‑Cu(II) complexes as anticancer candidates and support further studies into their mechanisms of action.

PMID:
43034084
Bibliographic data and abstract were imported from PubMed on 15 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement